These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 3829224

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R, Ohrloff C, Jungmann E, Maass K, Rinke S, Wagner A.
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [Abstract] [Full Text] [Related]

  • 27. Calcein fluorophotometry in streptozocin-induced diabetic rats.
    Golshani MR, Khoobehi B, Peyman GA, Aras C.
    Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
    [Abstract] [Full Text] [Related]

  • 28. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM.
    Retina; 1995 Aug; 15(2):134-40. PubMed ID: 7624601
    [Abstract] [Full Text] [Related]

  • 29. Vitreous fluorophotometric evaluation of diabetics.
    Bursell SE, Delori FC, Yoshida A, Parker JS, Collas GD, McMeel JW.
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Use of perindopril in the treatment of patients with diabetic retinopathy].
    Neroev VV, Riabina MV, Okhotsimskaia TD, Zueva MV, Tsapenko IV.
    Vestn Oftalmol; 2006 Jun; 122(4):31-3. PubMed ID: 16927782
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Fluorophotometry and the Fluorotron].
    Menerath JM, Solé P.
    Bull Soc Ophtalmol Fr; 1984 Dec; 84(12):1467-71. PubMed ID: 6544674
    [No Abstract] [Full Text] [Related]

  • 38. [Electrodiagnosis of retinal diseases (retinal rest and action potentials].
    François J, de Rouck A, Combie E, Zanen A.
    Bull Soc Belge Ophtalmol; 1974 Jan; 166(1):1-494. PubMed ID: 4361629
    [No Abstract] [Full Text] [Related]

  • 39. Fluorescein retinal angiography as an aid in ocular diagnosis.
    Edwards EC, Barbee JY, MacDonald R, Van Cader T.
    J Ky Med Assoc; 1969 Mar; 67(3):185-90. PubMed ID: 5774123
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.